PRIMARY STUDY

Flavonoid Derivative of Cannabis Demonstrates Therapeutic Potential in Preclinical Models of Metastatic Pancreatic Cancer

Key Findings:  The data from the trial demonstrated the potential therapeutic effects of a flavonoid derived from cannabis (the unnatural isomer of Cannflavin B) in the treatment of metastatic pancreatic cancer. In vitro results showed major increase in apoptosis while in vivo results demonstrate therapeutic efficacy in delaying both local and metastatic tumor progression in the animal models.